VALID Act Letter

VALID Act Letter

We sent a letter to Senate HELP Committee leadership to highlight the implications of the VALID Act.

We have sent a letter to Senate Health, Education, Labor and Pensions (HELP) Committee leadership that highlights the implications of the Verifying Accurate Leading-edge IVCT Development (VALID) Act. Because the bill would modify the regulatory framework for laboratory developed tests, the VALID Act could have serious unintended consequences for children’s health and children’s hospitals. We are asking the committee to address those concerns before advancing the Senate FDA user fee package legislation that includes the VALID Act. 

Related Content

Fiscal Year 2023 Omnibus Summary

This detailed summary of the FY 2023 Omnibus focuses on those provisions of most interest to children’s hospitals.

Jan. 13, 2023

Letter to FDA on Critical Shortages Affecting Pediatric Care

CHA sent a letter to the FDA asking the agency to address two critical shortages affecting children and families.

May 11, 2022

House Healthy Future Task Force Requests for Information Responses

CHA has submitted responses to several RFIs from the House Healthy Future Task Force.

March 11, 2022